Cargando…
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
BACKGROUND: Despite recent advances in treatment strategies, it is still difficult to cure patients with hepatocellular carcinoma (HCC). Sorafenib is the only approved multiple kinase inhibitor for systemic chemotherapy in patients with advanced HCC. The majority of advanced HCC patients are resista...
Autores principales: | Haga, Yuki, Kanda, Tatsuo, Nakamura, Masato, Nakamoto, Shingo, Sasaki, Reina, Takahashi, Koji, Wu, Shuang, Yokosuka, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360329/ https://www.ncbi.nlm.nih.gov/pubmed/28323861 http://dx.doi.org/10.1371/journal.pone.0174153 |
Ejemplares similares
-
Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2017) -
Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases
por: Haga, Yuki, et al.
Publicado: (2016) -
Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015) -
MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells
por: Nakamura, Masato, et al.
Publicado: (2015) -
Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells
por: Sasaki, Reina, et al.
Publicado: (2016)